Mma Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Mma Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Feb 05, 2025	BUY	$700.03 - $830.35 $259,011 - $307,229	370 New	370 $265,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $12,600 - $14,946	-18 Reduced 4.64%	370 $265,000
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $705 - $766	-1 Reduced 0.26%	388 $279,000
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $11,479 - $14,486	20 Added 5.42%	389 $268,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $219,599 - $257,720	369 New	369 $227,000

1,484

83.7M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Mma Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mma Asset Management LLC with notifications on news.